This is a Validated Antibody Database (VAD) review about human AURKA, based on 75 published articles (read how Labome selects the articles), using AURKA antibody in all methods. It is aimed to help Labome visitors find the most suited AURKA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
AURKA synonym: AIK; ARK1; AURA; BTAK; PPP1R47; STK15; STK6; STK7

Knockout validation
Cell Signaling Technology
domestic rabbit monoclonal (D3E4Q)
  • western blot knockout validation; human; loading ...; fig 3b
  • immunohistochemistry - paraffin section; human; loading ...; fig 2e
Cell Signaling Technology AURKA antibody (Cell signaling, 14475) was used in western blot knockout validation on human samples (fig 3b) and in immunohistochemistry - paraffin section on human samples (fig 2e). Clin Transl Med (2022) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (1G4)
  • western blot knockout validation; human; 1:500; loading ...; fig 4h, s5m
Cell Signaling Technology AURKA antibody (Cell Signaling, 4718) was used in western blot knockout validation on human samples at 1:500 (fig 4h, s5m). Nat Commun (2021) ncbi
Abcam
mouse monoclonal (35C1)
  • immunohistochemistry; human; loading ...; fig 4e
  • western blot; human; loading ...; fig 4c
Abcam AURKA antibody (Abcam, ab13824) was used in immunohistochemistry on human samples (fig 4e) and in western blot on human samples (fig 4c). Cell Death Dis (2022) ncbi
mouse monoclonal (35C1)
  • western blot; human; fig 4b
Abcam AURKA antibody (Abcam, ab13824) was used in western blot on human samples (fig 4b). Int J Med Sci (2021) ncbi
domestic rabbit monoclonal (EP1008Y)
  • western blot; human; 1:10,000; loading ...; fig s8h
Abcam AURKA antibody (Abcam, ab52973) was used in western blot on human samples at 1:10,000 (fig s8h). Nat Commun (2019) ncbi
mouse monoclonal (35C1)
  • western blot; mouse; 1:1000; loading ...; fig 5b
In order to study the role of microRNAs in the cell cycle and differentiation, Abcam AURKA antibody (Abcam, ab13824) was used in western blot on mouse samples at 1:1000 (fig 5b). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (EP1008Y)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
Abcam AURKA antibody (Abcam, ab52973) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Arch Gynecol Obstet (2016) ncbi
mouse monoclonal (35C1)
  • western blot; mouse; 1:500; fig 3
In order to research the drive of early signaling and vesicle dynamics during T-cell activation by Aurora A, Abcam AURKA antibody (Abcam, a13824) was used in western blot on mouse samples at 1:500 (fig 3). Nat Commun (2016) ncbi
  • immunocytochemistry; human; 1:200; fig 1
In order to research the drive of early signaling and vesicle dynamics during T-cell activation by Aurora A, Abcam AURKA antibody (Abcam, ab83968) was used in immunocytochemistry on human samples at 1:200 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (35C1)
  • chromatin immunoprecipitation; human; 1:4000; fig 4
  • immunohistochemistry; human; 1:4000; fig 1
  • western blot; human; 1:4000; fig 3
Abcam AURKA antibody (Abcam, ab13824) was used in chromatin immunoprecipitation on human samples at 1:4000 (fig 4), in immunohistochemistry on human samples at 1:4000 (fig 1) and in western blot on human samples at 1:4000 (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (35C1)
  • western blot; mouse; loading ...; fig 5a
In order to present the role of nuclear pore protein nup88 on anaphase-promoting complex, Abcam AURKA antibody (abcam, ab13824) was used in western blot on mouse samples (fig 5a). J Clin Invest (2016) ncbi
  • immunocytochemistry; human; 1:1000; fig s4
Abcam AURKA antibody (AbCam, ab83968) was used in immunocytochemistry on human samples at 1:1000 (fig s4). Nat Commun (2015) ncbi
mouse monoclonal (35C1)
  • immunocytochemistry; human; 1:1000; loading ...; fig 2a
Abcam AURKA antibody (Abcam, ab13824) was used in immunocytochemistry on human samples at 1:1000 (fig 2a). Mol Biol Cell (2015) ncbi
mouse monoclonal (35C1)
  • western blot; human; 1:500; fig 3
In order to assess the efficacy of alisertib against glioblastoma neurosphere tumor stem-like cells in vitro and in vivo, Abcam AURKA antibody (Abcam, ab13824) was used in western blot on human samples at 1:500 (fig 3). Cancer Res (2014) ncbi
mouse monoclonal (35C1)
  • western blot; mouse
  • western blot; human
Abcam AURKA antibody (Abcam, 35C1) was used in western blot on mouse samples and in western blot on human samples . Oncogene (2015) ncbi
mouse monoclonal (35C1)
  • western blot; mouse; fig s3
Abcam AURKA antibody (abcam, ab13824) was used in western blot on mouse samples (fig s3). Cell Cycle (2014) ncbi
mouse monoclonal (35C1)
  • western blot; human; 1:1000
Abcam AURKA antibody (Abcam, ab13824) was used in western blot on human samples at 1:1000. J Biol Chem (2013) ncbi
mouse monoclonal (35C1)
  • immunocytochemistry; chicken; 1:500
Abcam AURKA antibody (Abcam, 35C1) was used in immunocytochemistry on chicken samples at 1:500. Cell Cycle (2013) ncbi
Invitrogen
domestic rabbit monoclonal (F.131.2)
  • western blot; human; 1:1000; loading ...; fig 4d
Invitrogen AURKA antibody (Thermo Fisher Scientific, MA5-14904) was used in western blot on human samples at 1:1000 (fig 4d). Nat Commun (2018) ncbi
domestic rabbit monoclonal (F.131.2)
  • western blot; human; 1:2000; fig 1
In order to develop and characterize a Forster's resonance energy transfer-based aurora kinase A biosensor, Invitrogen AURKA antibody (ThermoFisher Scientific, MA5-14904) was used in western blot on human samples at 1:2000 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (35C1)
  • western blot; human; 1:1000; fig s5
In order to analyze prevention of centrosome amplification and neoplastic progression by 14-3-3gamma, Invitrogen AURKA antibody (Invitrogen, 458900) was used in western blot on human samples at 1:1000 (fig s5). Sci Rep (2016) ncbi
mouse monoclonal (35C1)
  • western blot; human; fig 3s
In order to examine how histone H3 threonine 118 alters chromosome structure, Invitrogen AURKA antibody (Invitrogen, 45-C8900) was used in western blot on human samples (fig 3s). elife (2016) ncbi
mouse monoclonal (35C1)
  • western blot; mouse
Invitrogen AURKA antibody (Invitrogen, 35C1) was used in western blot on mouse samples . Oncotarget (2015) ncbi
GeneTex
mouse monoclonal (35C1)
  • western blot; human; fig 2
  • western blot; mouse; fig 1
GeneTex AURKA antibody (GeneTex, GTX13824) was used in western blot on human samples (fig 2) and in western blot on mouse samples (fig 1). Nat Med (2015) ncbi
mouse monoclonal (35C1)
  • immunocytochemistry; human
  • western blot; human
GeneTex AURKA antibody (GeneTex, GTX13824) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2012) ncbi
mouse monoclonal (35C1)
  • western blot; human; fig 1
GeneTex AURKA antibody (GeneTex, GTX13824) was used in western blot on human samples (fig 1). Clin Cancer Res (2010) ncbi
Bio-Rad
mouse monoclonal (35C1)
  • reverse phase protein lysate microarray; human
Bio-Rad AURKA antibody (Serotec, MCA2249) was used in reverse phase protein lysate microarray on human samples . Haematologica (2013) ncbi
mouse monoclonal (35C1)
  • reverse phase protein lysate microarray; human
  • western blot; human
Bio-Rad AURKA antibody (Serotec, MCA2249) was used in reverse phase protein lysate microarray on human samples and in western blot on human samples . Leukemia (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (35C1)
  • western blot; human; 1:500; loading ...; fig 6e; S6n; S6i
In order to report FOSL1 as a common transcriptional signature across mutant KRAS cancers of distinct tissue origin, Santa Cruz Biotechnology AURKA antibody (Santa Cruz, sc-56881) was used in western blot on human samples at 1:500 (fig 6e; S6n; S6i). Nat Commun (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D3E4Q)
  • western blot knockout validation; human; loading ...; fig 3b
  • immunohistochemistry - paraffin section; human; loading ...; fig 2e
Cell Signaling Technology AURKA antibody (Cell signaling, 14475) was used in western blot knockout validation on human samples (fig 3b) and in immunohistochemistry - paraffin section on human samples (fig 2e). Clin Transl Med (2022) ncbi
domestic rabbit monoclonal (1G4)
  • western blot knockout validation; human; 1:500; loading ...; fig 4h, s5m
Cell Signaling Technology AURKA antibody (Cell Signaling, 4718) was used in western blot knockout validation on human samples at 1:500 (fig 4h, s5m). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D3E4Q)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 14475) was used in western blot on human samples (fig 5e). Oncogene (2021) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 3079) was used in western blot on human samples (fig 5e). Oncogene (2021) ncbi
domestic rabbit monoclonal (D3E4Q)
  • western blot; human; fig 3b
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 14475) was used in western blot on human samples (fig 3b). Nature (2020) ncbi
domestic rabbit monoclonal (D3E4Q)
  • western blot; human; loading ...; fig 8f
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, D3E4Q) was used in western blot on human samples (fig 8f). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D3E4Q)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology AURKA antibody (Cell Signaling, 14475) was used in western blot on human samples (fig 4b). Br J Cancer (2019) ncbi
domestic rabbit monoclonal (C39D8)
  • immunocytochemistry; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology AURKA antibody (Cell Signaling, 3079) was used in immunocytochemistry on human samples at 1:1000 (fig 5c). Mol Cancer Res (2018) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human; 1:500; loading ...; fig 1b
In order to identify Aurora kinase A as a novel Ras binding protein, Cell Signaling Technology AURKA antibody (Cell Signaling, 4718) was used in western blot on human samples at 1:500 (fig 1b). Oncotarget (2017) ncbi
mouse monoclonal (1F8)
  • immunohistochemistry - paraffin section; human; 1:500; fig 5a
  • western blot; human; 1:500; fig 5c
Cell Signaling Technology AURKA antibody (Cell Signaling, 12100) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 5a) and in western blot on human samples at 1:500 (fig 5c). BMC Pulm Med (2017) ncbi
domestic rabbit monoclonal (D3E4Q)
  • western blot; human; 1:500; loading ...; fig 1a
Cell Signaling Technology AURKA antibody (Cell Signaling, 14475) was used in western blot on human samples at 1:500 (fig 1a). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human; 1:1000; loading ...; fig s6a
In order to find AURKA activity as essential in non-small cell lung cancer cells lacking SMARCA4/BRG1, Cell Signaling Technology AURKA antibody (Cell signaling, 4718) was used in western blot on human samples at 1:1000 (fig s6a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (1G4)
  • immunocytochemistry; human; loading ...; fig 3
Cell Signaling Technology AURKA antibody (Cell Signaling, 4718) was used in immunocytochemistry on human samples (fig 3). Int J Oncol (2017) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology AURKA antibody (Cell signaling, 3079) was used in western blot on human samples (fig 1f). Oncotarget (2016) ncbi
mouse monoclonal (1F8)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology AURKA antibody (Cell signaling, 12100) was used in western blot on human samples (fig 1f). Oncotarget (2016) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology AURKA antibody (Cell Signaling, 4718) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology AURKA antibody (Cell Signaling, 3079) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • immunocytochemistry; mouse; 1:30; loading ...; fig 4a
In order to determine the role of haspin in bipolar spindle assembly, Cell Signaling Technology AURKA antibody (Cell Signaling, 3079S) was used in immunocytochemistry on mouse samples at 1:30 (fig 4a). J Cell Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500
In order to describe a novel irreversible DNA-damage response in antephase, Cell Signaling Technology AURKA antibody (Cell Signaling, 3092) was used in western blot on human samples at 1:500. Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s3h
In order to elucidate how Cdh1 regulates NEDD4 family E3 ligases such as WWP2, Cell Signaling Technology AURKA antibody (Cell Signaling, 3092) was used in western blot on human samples (fig s3h). Cell Discov (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3b
Cell Signaling Technology AURKA antibody (Cell Signaling, 3092S) was used in western blot on human samples at 1:1000 (fig 3b). Biol Open (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; 1:1000; fig s5
In order to analyze prevention of centrosome amplification and neoplastic progression by 14-3-3gamma, Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 3079) was used in western blot on human samples at 1:1000 (fig s5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human; fig 2
Cell Signaling Technology AURKA antibody (Cell signaling, 4718) was used in western blot on human samples (fig 2). Cell Cycle (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:1000; fig 1
In order to compare regulation of a Golgi-activated pool of Src during G2 by centrosomal maturation and Aurora-A recruitment, Cell Signaling Technology AURKA antibody (Cell Signaling, 3,092) was used in immunocytochemistry on human samples at 1:1000 (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • immunocytochemistry; human; 1:500; fig s5
In order to compare regulation of a Golgi-activated pool of Src during G2 by centrosomal maturation and Aurora-A recruitment, Cell Signaling Technology AURKA antibody (Cell Signaling, 3,079) was used in immunocytochemistry on human samples at 1:500 (fig s5). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D3E4Q)
  • western blot; mouse; loading ...; fig 6a
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology AURKA antibody (Cell Signaling, 14475) was used in western blot on mouse samples (fig 6a) and in western blot on human samples (fig 5c). Carcinogenesis (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 1
Cell Signaling Technology AURKA antibody (Cell Signal, 3092) was used in western blot on mouse samples (fig 1). Cell Rep (2016) ncbi
mouse monoclonal (1F8)
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology AURKA antibody (cell signalling, 12100) was used in western blot on human samples (fig 7a). EMBO Rep (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology AURKA antibody (cell signalling, 3079) was used in western blot on human samples (fig 7a). EMBO Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig s3
In order to study APC/C(Cdh1) function, Cell Signaling Technology AURKA antibody (Cell signalling, 3092) was used in western blot on human samples at 1:500 (fig s3). Nucleic Acids Res (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • immunocytochemistry; human; fig 3s
In order to examine how histone H3 threonine 118 alters chromosome structure, Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 3079) was used in immunocytochemistry on human samples (fig 3s). elife (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; fig 2
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 3079) was used in western blot on human samples (fig 2). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human; fig 3
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 4718) was used in western blot on human samples (fig 3). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; fig 2
Cell Signaling Technology AURKA antibody (Cell Signaling, 3079) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology AURKA antibody (Cell Signaling, 3092) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human; 1:1000; fig s11
Cell Signaling Technology AURKA antibody (cell Signaling Tech, C4718T) was used in western blot on human samples at 1:1000 (fig s11). PLoS Genet (2015) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human; fig 6
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 4718) was used in western blot on human samples (fig 6). Mol Biosyst (2015) ncbi
domestic rabbit monoclonal (C39D8)
  • immunohistochemistry; human; 1:1000; fig 6
Cell Signaling Technology AURKA antibody (Cell Signaling, 3079) was used in immunohistochemistry on human samples at 1:1000 (fig 6). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human; fig 2
In order to explore how Tpr regulated chromosomal segregation, Cell Signaling Technology AURKA antibody (Cell Signaling, 3079S) was used in western blot on human samples (fig 2). Cell Cycle (2015) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; mouse; 1:100
Cell Signaling Technology AURKA antibody (Cell Signaling, C39D8) was used in western blot on mouse samples at 1:100. Nat Cell Biol (2015) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; human
In order to elucidate the mechanism by which BI2536 induces defects in cell proliferation of non-small cell lung cancer, Cell Signaling Technology AURKA antibody (cst, 4718) was used in western blot on human samples . Cancer Lett (2015) ncbi
domestic rabbit monoclonal (1G4)
  • western blot; mouse
In order to assess broad patterns of signaling pathway activity during in vitro oocyte aging, Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 4718S) was used in western blot on mouse samples . Mol Reprod Dev (2014) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; human
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 3079) was used in western blot on human samples . Oncotarget (2014) ncbi
domestic rabbit monoclonal (C39D8)
  • immunocytochemistry; human
Cell Signaling Technology AURKA antibody (Cell Signalling, 3079) was used in immunocytochemistry on human samples . Stem Cell Res (2014) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; Xenopus laevis; 1:5,000
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, 3079) was used in western blot on Xenopus laevis samples at 1:5,000. J Biol Chem (2014) ncbi
domestic rabbit monoclonal (C39D8)
  • immunocytochemistry; human; 1:200
  • western blot; human; 1:1000
Cell Signaling Technology AURKA antibody (Cell Signaling Technologies, 3079) was used in immunocytochemistry on human samples at 1:200 and in western blot on human samples at 1:1000. J Biol Chem (2013) ncbi
domestic rabbit monoclonal (C39D8)
  • western blot; mouse
Cell Signaling Technology AURKA antibody (Cell Signaling Technology, C39D8) was used in western blot on mouse samples . Leuk Res (2013) ncbi
domestic rabbit monoclonal (C39D8)
  • immunocytochemistry; human
Cell Signaling Technology AURKA antibody (Cell Signalling Technologies, 3079) was used in immunocytochemistry on human samples . Br J Cancer (2012) ncbi
BD Biosciences
mouse monoclonal (4/IAK1)
  • western blot; mouse; 1:1000; loading ...; fig 8a
BD Biosciences AURKA antibody (BD Transduction, 610938) was used in western blot on mouse samples at 1:1000 (fig 8a). elife (2020) ncbi
mouse monoclonal (4/IAK1)
  • western blot; human; 1:1000; loading ...; fig 4d
BD Biosciences AURKA antibody (BD Biosciences, 610938) was used in western blot on human samples at 1:1000 (fig 4d). Nat Commun (2018) ncbi
mouse monoclonal (4/IAK1)
  • western blot; human; loading ...; fig 3A
BD Biosciences AURKA antibody (BD, 610939) was used in western blot on human samples (fig 3A). J Cell Biol (2016) ncbi
mouse monoclonal (4/IAK1)
  • western blot; human; 1:1000; fig 3
In order to compare regulation of a Golgi-activated pool of Src during G2 by centrosomal maturation and Aurora-A recruitment, BD Biosciences AURKA antibody (BD Biosciences, 610,938) was used in western blot on human samples at 1:1000 (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (4/IAK1)
  • western blot; mouse; 1:500; fig 3
In order to characterize a novel population of binucleated mammary epithelial cells and their essential role in lactation, BD Biosciences AURKA antibody (BD, 4/IAK1) was used in western blot on mouse samples at 1:500 (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (4/IAK1)
  • immunoprecipitation; mouse; fig 2e
BD Biosciences AURKA antibody (BD Biosciences, 610938) was used in immunoprecipitation on mouse samples (fig 2e). elife (2016) ncbi
mouse monoclonal (4/IAK1)
  • western blot; mouse
In order to investigate changes to AURKA signaling after treatment with erlotinib/alisertib combination therapy, BD Biosciences AURKA antibody (BD Transduction, 610939) was used in western blot on mouse samples . Front Oncol (2015) ncbi
mouse monoclonal (4/IAK1)
  • western blot; human; 1:1000; fig 1
BD Biosciences AURKA antibody (BD Biosciences, 610939) was used in western blot on human samples at 1:1000 (fig 1). Mol Biol Cell (2015) ncbi
mouse monoclonal (4/IAK1)
  • western blot; human; fig 3
BD Biosciences AURKA antibody (BD Biosciences, 610939) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
mouse monoclonal (4/IAK1)
  • western blot; human; fig 2
In order to explore how Tpr regulated chromosomal segregation, BD Biosciences AURKA antibody (BD Transduction, 610939) was used in western blot on human samples (fig 2). Cell Cycle (2015) ncbi
mouse monoclonal (4/IAK1)
  • western blot; mouse; 1:1000
BD Biosciences AURKA antibody (BD biosciences, 610938) was used in western blot on mouse samples at 1:1000. Nat Cell Biol (2015) ncbi
mouse monoclonal (4/IAK1)
  • immunocytochemistry; human
In order to elucidate the mechanism by which BI2536 induces defects in cell proliferation of non-small cell lung cancer, BD Biosciences AURKA antibody (BD, 610938) was used in immunocytochemistry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (4/IAK1)
  • immunoprecipitation; human; fig s10
BD Biosciences AURKA antibody (BD Biosciences, 610938) was used in immunoprecipitation on human samples (fig s10). Nat Commun (2014) ncbi
mouse monoclonal (4/IAK1)
  • western blot; mouse; 1:1000; fig s6
  • western blot; human; 1:1000; fig 7
BD Biosciences AURKA antibody (BD Biosciences, 610938) was used in western blot on mouse samples at 1:1000 (fig s6) and in western blot on human samples at 1:1000 (fig 7). Nat Commun (2014) ncbi
mouse monoclonal (4/IAK1)
  • western blot; human
BD Biosciences AURKA antibody (BD Pharmingen, 610938) was used in western blot on human samples . J Natl Cancer Inst (2014) ncbi
MilliporeSigma
mouse monoclonal (35C1)
  • immunoprecipitation; human; 1:50; loading ...; fig 1d
In order to identify Aurora kinase A as a novel Ras binding protein, MilliporeSigma AURKA antibody (Sigma, A1231) was used in immunoprecipitation on human samples at 1:50 (fig 1d). Oncotarget (2017) ncbi
mouse monoclonal (35C1)
  • western blot; chicken; fig 1
MilliporeSigma AURKA antibody (Sigma, A1231) was used in western blot on chicken samples (fig 1). PLoS Genet (2015) ncbi
Articles Reviewed
  1. Jiang H, Wang Y, Wang J, Wang Y, Wang S, He E, et al. Posttranslational modification of Aurora A-NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma. Clin Transl Med. 2022;12:e744 pubmed publisher
  2. Shen M, Zhang R, Jia W, Zhu Z, Zhao L, Huang G, et al. RNA-binding protein p54nrb/NONO potentiates nuclear EGFR-mediated tumorigenesis of triple-negative breast cancer. Cell Death Dis. 2022;13:42 pubmed publisher
  3. Han J, Chen X, Xu J, Chu L, Li R, Sun N, et al. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1. Int J Med Sci. 2021;18:3437-3451 pubmed publisher
  4. Vichas A, Riley A, Nkinsi N, Kamlapurkar S, Parrish P, Lo A, et al. Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. Nat Commun. 2021;12:4789 pubmed publisher
  5. Fischietti M, Eckerdt F, Blyth G, Arslan A, Mati W, Oku C, et al. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene. 2021;40:3273-3286 pubmed publisher
  6. Yoshida S, Aoki K, Fujiwara K, Nakakura T, Kawamura A, Yamada K, et al. The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis. elife. 2020;9: pubmed publisher
  7. Xue J, Zhao Y, Aronowitz J, Mai T, Vides A, Qeriqi B, et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature. 2020;577:421-425 pubmed publisher
  8. Lee Y, Ho S, Graves J, Xiao Y, Huang S, Lin W. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer. Breast Cancer Res. 2019;21:134 pubmed publisher
  9. Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun. 2019;10:5492 pubmed publisher
  10. Dufour F, Silina L, Neyret Kahn H, Moreno Vega A, Krucker C, Karboul N, et al. TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer. Br J Cancer. 2019;120:555-564 pubmed publisher
  11. Lin C, Kitagawa M, Tang X, Hou M, Wu J, Qu D, et al. CoA synthase regulates mitotic fidelity via CBP-mediated acetylation. Nat Commun. 2018;9:1039 pubmed publisher
  12. Chu T, Connell M, Zhou L, He Z, Won J, Chen H, et al. Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A. Mol Cancer Res. 2018;16:16-31 pubmed publisher
  13. Otto T, Candido S, Pilarz M, Sicinska E, Bronson R, Bowden M, et al. Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit. Proc Natl Acad Sci U S A. 2017;114:10660-10665 pubmed publisher
  14. Vallejo A, Perurena N, Guruceaga E, Mazur P, Martínez Canarias S, Zandueta C, et al. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. Nat Commun. 2017;8:14294 pubmed publisher
  15. Umstead M, Xiong J, Qi Q, Du Y, Fu H. Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling. Oncotarget. 2017;8:28359-28372 pubmed publisher
  16. Stefanowicz D, Ullah J, Lee K, Shaheen F, Olumese E, Fishbane N, et al. Epigenetic modifying enzyme expression in asthmatic airway epithelial cells and fibroblasts. BMC Pulm Med. 2017;17:24 pubmed publisher
  17. Gan J, Wang F, Mu D, Qu Y, Luo R, Wang Q. RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy. Oncol Lett. 2016;12:4515-4523 pubmed publisher
  18. Tagal V, Wei S, Zhang W, Brekken R, Posner B, Peyton M, et al. SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers. Nat Commun. 2017;8:14098 pubmed publisher
  19. Schneider M, Christopoulos P, Muley T, Warth A, Klingmueller U, Thomas M, et al. AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients. Int J Oncol. 2017;50:365-372 pubmed publisher
  20. Fang Y, Kong Y, Xi J, Zhu M, Zhu T, Jiang T, et al. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity. Oncotarget. 2016;7:79327-79341 pubmed publisher
  21. Uematsu K, Okumura F, Tonogai S, Joo Okumura A, Alemayehu D, Nishikimi A, et al. ASB7 regulates spindle dynamics and genome integrity by targeting DDA3 for proteasomal degradation. J Cell Biol. 2016;215:95-106 pubmed
  22. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  23. Bertolin G, Sizaire F, Herbomel G, Reboutier D, Prigent C, Tramier M. A FRET biosensor reveals spatiotemporal activation and functions of aurora kinase A in living cells. Nat Commun. 2016;7:12674 pubmed publisher
  24. Balboula A, Nguyen A, Gentilello A, Quartuccio S, Drutovic D, Solc P, et al. Haspin kinase regulates microtubule-organizing center clustering and stability through Aurora kinase C in mouse oocytes. J Cell Sci. 2016;129:3648-3660 pubmed
  25. Feringa F, Krenning L, Koch A, van den Berg J, van den Broek B, Jalink K, et al. Hypersensitivity to DNA damage in antephase as a safeguard for genome stability. Nat Commun. 2016;7:12618 pubmed publisher
  26. Liu J, Wan L, Liu J, Yuan Z, Zhang J, Guo J, et al. Cdh1 inhibits WWP2-mediated ubiquitination of PTEN to suppress tumorigenesis in an APC-independent manner. Cell Discov. 2016;2:15044 pubmed publisher
  27. Polacchini A, Albani C, Baj G, Colliva A, Carpinelli P, Tongiorgi E. Combined cisplatin and aurora inhibitor treatment increase neuroblastoma cell death but surviving cells overproduce BDNF. Biol Open. 2016;5:899-907 pubmed publisher
  28. Mukhopadhyay A, Sehgal L, Bose A, Gulvady A, Senapati P, Thorat R, et al. 14-3-3? Prevents Centrosome Amplification and Neoplastic Progression. Sci Rep. 2016;6:26580 pubmed publisher
  29. Qi D, Wang Q, Yu M, Lan R, Li S, Lu F. Mitotic phosphorylation of SOX2 mediated by Aurora kinase A is critical for the stem-cell like cell maintenance in PA-1 cells. Cell Cycle. 2016;15:2009-18 pubmed publisher
  30. Barretta M, Spano D, D Ambrosio C, Cervigni R, Scaloni A, Corda D, et al. Aurora-A recruitment and centrosomal maturation are regulated by a Golgi-activated pool of Src during G2. Nat Commun. 2016;7:11727 pubmed publisher
  31. Sun F, Zhang Z, Tan E, Lim Z, Li Y, Wang X, et al. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice. Carcinogenesis. 2016;37:701-711 pubmed publisher
  32. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  33. Sánchez A, Urrego D, Pardo L. Cyclic expression of the voltage-gated potassium channel KV10.1 promotes disassembly of the primary cilium. EMBO Rep. 2016;17:708-23 pubmed publisher
  34. Rios A, Fu N, Jamieson P, Pal B, Whitehead L, Nicholas K, et al. Essential role for a novel population of binucleated mammary epithelial cells in lactation. Nat Commun. 2016;7:11400 pubmed publisher
  35. Heilmann T, Dittmann L, van Mackelenbergh M, Mundhenke C, Weimer J, Arnold N, et al. Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant gynaecological tumor entities. Arch Gynecol Obstet. 2016;294:813-23 pubmed publisher
  36. Blas Rus N, Bustos Morán E, Perez de Castro I, de Carcer G, Borroto A, Camafeita E, et al. Aurora A drives early signalling and vesicle dynamics during T-cell activation. Nat Commun. 2016;7:11389 pubmed publisher
  37. Ercilla A, Llopis A, Feu S, Aranda S, Ernfors P, Freire R, et al. New origin firing is inhibited by APC/CCdh1 activation in S-phase after severe replication stress. Nucleic Acids Res. 2016;44:4745-62 pubmed publisher
  38. Shin J, Kim T, Kim H, Kim H, Suh M, Lee S, et al. Aurkb/PP1-mediated resetting of Oct4 during the cell cycle determines the identity of embryonic stem cells. elife. 2016;5:e10877 pubmed publisher
  39. Wike C, Graves H, Hawkins R, Gibson M, Ferdinand M, Zhang T, et al. Aurora-A mediated histone H3 phosphorylation of threonine 118 controls condensin I and cohesin occupancy in mitosis. elife. 2016;5:e11402 pubmed publisher
  40. Dos Santos E, Carneiro Lobo T, Aoki M, Levantini E, Bassères D. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation. Mol Cancer. 2016;15:12 pubmed publisher
  41. Chen N, Chyau C, Lee Y, Tseng H, Chou F. Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells. Sci Rep. 2016;6:20417 pubmed publisher
  42. Zheng F, Yue C, Li G, He B, Cheng W, Wang X, et al. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat Commun. 2016;7:10180 pubmed publisher
  43. Naylor R, Jeganathan K, Cao X, van Deursen J. Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. J Clin Invest. 2016;126:543-59 pubmed publisher
  44. Wen Q, Yang Q, Goldenson B, Malinge S, Lasho T, Schneider R, et al. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med. 2015;21:1473-80 pubmed publisher
  45. Nikonova A, Deneka A, Eckman L, Kopp M, Hensley H, Egleston B, et al. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease. Front Oncol. 2015;5:228 pubmed publisher
  46. Min M, Mevissen T, De Luca M, Komander D, Lindon C. Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkages. Mol Biol Cell. 2015;26:4325-32 pubmed publisher
  47. Aviner R, Shenoy A, Elroy Stein O, Geiger T. Uncovering Hidden Layers of Cell Cycle Regulation through Integrative Multi-omic Analysis. PLoS Genet. 2015;11:e1005554 pubmed publisher
  48. Qi D, Wang Q, Li H, Zhang T, Lan R, Kwong D, et al. SILAC-based quantitative proteomics identified lysosome as a fast response target to PDT agent Gd-N induced oxidative stress in human ovarian cancer IGROV1 cells. Mol Biosyst. 2015;11:3059-67 pubmed publisher
  49. Burgess S, Peset I, Joseph N, Cavazza T, Vernos I, Pfuhl M, et al. Aurora-A-Dependent Control of TACC3 Influences the Rate of Mitotic Spindle Assembly. PLoS Genet. 2015;11:e1005345 pubmed publisher
  50. Whalley H, Porter A, Diamantopoulou Z, White G, Castañeda Saucedo E, Malliri A. Cdk1 phosphorylates the Rac activator Tiam1 to activate centrosomal Pak and promote mitotic spindle formation. Nat Commun. 2015;6:7437 pubmed publisher
  51. Chang D, Moniz R, Xu Z, Sun J, Signoretti S, Zhu Q, et al. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Mol Cancer. 2015;14:119 pubmed publisher
  52. Park S, Shim J, Park H, Eum D, Park M, Mi Yi J, et al. MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B. Oncogene. 2016;35:1292-301 pubmed publisher
  53. Kobayashi A, Hashizume C, Dowaki T, Wong R. Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A. Cell Cycle. 2015;14:1447-58 pubmed publisher
  54. Ohta S, Wood L, Toramoto I, Yagyu K, Fukagawa T, Earnshaw W. CENP-32 is required to maintain centrosomal dominance in bipolar spindle assembly. Mol Biol Cell. 2015;26:1225-37 pubmed publisher
  55. Bangs F, Schrode N, Hadjantonakis A, Anderson K. Lineage specificity of primary cilia in the mouse embryo. Nat Cell Biol. 2015;17:113-22 pubmed publisher
  56. Rizkallah R, Batsomboon P, Dudley G, Hurt M. Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins. Oncotarget. 2015;6:1446-61 pubmed
  57. Choi M, Kim W, Cheon M, Lee C, Kim J. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells. Cancer Lett. 2015;357:591-601 pubmed publisher
  58. Kim M, Kim M, Lee M, Kim C, Lim D. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis. Nat Commun. 2014;5:5370 pubmed publisher
  59. McGinnis L, Pelech S, Kinsey W. Post-ovulatory aging of oocytes disrupts kinase signaling pathways and lysosome biogenesis. Mol Reprod Dev. 2014;81:928-45 pubmed publisher
  60. Xu L, Long Z, Peng F, Liu Y, Xu J, Wang C, et al. Aurora kinase a suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells. Oncotarget. 2014;5:7498-511 pubmed
  61. Van Brocklyn J, Wojton J, Meisen W, Kellough D, Ecsedy J, Kaur B, et al. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014;74:5364-70 pubmed publisher
  62. Vassilopoulos A, Tominaga Y, Kim H, Lahusen T, Li B, Yu H, et al. WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis. Oncogene. 2015;34:3023-35 pubmed publisher
  63. Piazzolla D, Palla A, Pantoja C, Canamero M, de Castro I, Ortega S, et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun. 2014;5:4226 pubmed publisher
  64. Mannino M, Gomez Roman N, Hochegger H, Chalmers A. Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics. Stem Cell Res. 2014;13:135-43 pubmed publisher
  65. Aydin I, Melamed R, Adams S, Castillo Martin M, Demir A, Bryk D, et al. FBXW7 mutations in melanoma and a new therapeutic paradigm. J Natl Cancer Inst. 2014;106:dju107 pubmed publisher
  66. Kang Q, Srividhya J, Ipe J, Pomerening J. Evidence toward a dual phosphatase mechanism that restricts Aurora A (Thr-295) phosphorylation during the early embryonic cell cycle. J Biol Chem. 2014;289:17480-96 pubmed publisher
  67. d Alcontres M, Palacios J, Mejias D, Blasco M. TopoII? prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres. Cell Cycle. 2014;13:1463-81 pubmed publisher
  68. Tan E, Caro S, Potnis A, Lanza C, Slawson C. O-linked N-acetylglucosamine cycling regulates mitotic spindle organization. J Biol Chem. 2013;288:27085-99 pubmed publisher
  69. Hartsink Segers S, Exalto C, Allen M, Williamson D, Clifford S, Horstmann M, et al. Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells. Haematologica. 2013;98:1539-46 pubmed publisher
  70. Wang Y, Dantas T, Lalor P, Dockery P, Morrison C. Promoter hijack reveals pericentrin functions in mitosis and the DNA damage response. Cell Cycle. 2013;12:635-46 pubmed publisher
  71. Qi W, Spier C, Liu X, Agarwal A, Cooke L, Persky D, et al. Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment. Leuk Res. 2013;37:434-9 pubmed publisher
  72. Pakala S, Nair V, Reddy S, Kumar R. Signaling-dependent phosphorylation of mitotic centromere-associated kinesin regulates microtubule depolymerization and its centrosomal localization. J Biol Chem. 2012;287:40560-9 pubmed publisher
  73. Lin Y, Richards F, Krippendorff B, Bramhall J, Harrington J, Bapiro T, et al. Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells. Br J Cancer. 2012;107:1692-701 pubmed publisher
  74. Hartsink Segers S, Zwaan C, Exalto C, Luijendijk M, Calvert V, Petricoin E, et al. Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia. 2013;27:560-8 pubmed publisher
  75. Yang G, Chang B, Yang F, Guo X, Cai K, Xiao X, et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res. 2010;16:3171-81 pubmed publisher